Biotechnology News

October 8, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vaxart, a privately held, clinical-stage company developing recombinant vaccines that are administered by tablet rather than by injection, today announced that Vaxart founder and chief scientific...

October 8, 2014

LEWISVILLE, Texas & CLEVELAND--(BUSINESS WIRE)--med fusion, an integrated molecular center of excellence and clinical trials service organization and GenomOncology, an Ohio based genomics technology and services provider, today announced a...

October 8, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today it will present the results of a Phase 2, randomized study to evaluate co-administration of the company’s investigational meningococcal group B vaccine, bivalent recombinant LP2086...

October 8, 2014

WOBURN, Mass.--(BUSINESS WIRE)--Aphios today announced that it has been granted United States Patent for the nanotechnology formulation of poorly soluble compounds for difficult to formulate and deliver drugs.

October 8, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics, Inc. to Raise $13.5 Million in Registered Direct Offering

October 8, 2014

DALLAS & FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos”), a specialty pharmaceutical company with a portfolio of novel and proprietary oral drug delivery technologies as well as a late-stage pipeline of innovative...

October 8, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) announced today that researchers will present a poster at IDWeek 2014 showing the preclinical activity of eravacycline, a novel tetracycline in late-stage clinical...

October 8, 2014

NEEDHAM, Mass.--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that it will present new data at the 12th International...

October 8, 2014

WASHINGTON--(BUSINESS WIRE)--As a cap to Clinical Research Innovation Month, the ACRO today released a report titled Clinical Research: A Legacy of Innovation, A Future of Transformed Medicine

October 8, 2014

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company focused on the discovery and development of G protein coupled receptor (GPCR) biased ligands, today announced that it has closed...

October 8, 2014

KNOXVILLE, Tenn.--(BUSINESS WIRE)--PROVECTUS’ INTRALESIONAL PV-10 CLINICAL DATA TO BE PRESENTED TO THE EURASIAN FEDERATION OF ONCOLOGY; III Eurasian Melanoma and Skin Cancers Forum, October 10-12, 2014

October 8, 2014

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience announces NCI SBIR Phase II funding for clinical trial of Tumor Paint(TM) BLZ-100 in sarcoma. BLZ-100 clinical program expands beyond brain and skin cancers.

October 8, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Essen BioScience, Inc., a leading provider of critical analytical instrumentation, software, reagents and services used in cell-based life science research, names Brett Williams President and CEO.

October 8, 2014

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEngine Inc. (TWO: 4162), a biopharmaceutical company developing new cancer treatments, and Nanobiotix S.A. (Euronext: NANO), a clinical-stage nanomedicine company pioneering in novel approaches for local...

October 8, 2014

DUNDEE, Scotland--(BUSINESS WIRE)--Ubiquigent and University of Dundee Announce Collaboration to Design, Develop and Market Novel Ubiquitin System Targeted Compound Libraries.

October 8, 2014

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Diagenic ASA – Signed final agreement to acquire NEL Hydrogen AS – extended announcement Reference is made to the stock exchange announcement made by Diagenic ASA ("Diagenic" or the "Company") on 8...

October 8, 2014

CROISSY-BEAUBOURG, France & MONTPELLIER, France--(BUSINESS WIRE)--THERADIAG - Monitoring of biotherapeutic treatments of Crohn’s disease could produce savings of more than €130 million in France

October 7, 2014

WASHINGTON--(BUSINESS WIRE)--The USDA today issued a report and commissioned a larger report on the jobs and economic opportunities created by the biobased products and renewable chemical industries, which BIO represents.

October 7, 2014

RIVERSIDE, Calif.--(BUSINESS WIRE)--ieCrowd, the discovery-to-market commercialization platform for innovations with the potential to solve global challenges, today announced plans to commercialize a new class of intelligent supplemental oxygen...

October 7, 2014

CHESHIRE, Conn.--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Max Link, Ph.D., Chairman of the Board of Directors of Alexion, passed away unexpectedly on October 5 while traveling on business.

October 7, 2014

WITTEN, Germany--(BUSINESS WIRE)--According to preliminary, unaudited figures Sangui BioTech International, Inc. yielded revenues from royalties and product sales of more than USD70,000 in the course of the first quarter of its financial year...

October 7, 2014

NEW YORK--(BUSINESS WIRE)--M&A firm advises leading market access agency in the pharmaceutical and biotech industries in its sale to the health behavior experts of Ogilvy & Mather.

October 7, 2014

MILFORD, Conn.--(BUSINESS WIRE)--Kubtec announces FDA approval of the world’s first specimen tomosynthesis radiography system, providing high resolution 3D image slices for comprehensive margin confirmation of excised breast tissue.

October 7, 2014

SINGAPORE--(BUSINESS WIRE)--PrIME Biologics Private Limited today announced investments from Xeraya Capital Labuan Ltd via its affiliate, Pulau Manukan Ventures Labuan Ltd, and JP Asia Prime Capital Pte Ltd. This investment will enable PrIME...

October 7, 2014

CRANFORD, N.J.--(BUSINESS WIRE)--Paragon Solutions, Inc., an advisory consulting and systems integration firm, today announced several appointments to its Life Sciences Research and Development (R&D) practice team to better serve its growing...

October 7, 2014

ANAHEIM, Calif.--(BUSINESS WIRE)--The Health Care IT Value Model is unveiled to a crowd of 1,000+ health and human services providers, setting the groundwork for improving health care.

October 7, 2014

WAPATO, Wash.--(BUSINESS WIRE)--Pace International LLC announced it has received an Experimental Use Permit (EUP) from the U.S. EPA for FYSIUM™, a new 1-MCP technology that will help apple packers in the United States improve the quality and...

October 7, 2014

NEWTOWN, Pa.--(BUSINESS WIRE)--Helius Medical Technologies is granted U.S. Patent No. 8,849,407, “Non-Invasive Neuromodulation (NINM) for Rehabilitation of Brain Function

October 7, 2014

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences and ArborGen agree to incorporate Arcadia’s water use efficiency (WUE) and nitrogen use efficiency (NUE) technologies.

October 7, 2014

MONROVIA, Calif.--(BUSINESS WIRE)--Immunotech Laboratories, Inc. (OTCMARKETS: IMMB) and Immunotech Laboratories, BG. recently announced the successful completion of Phase I and Phase II field trials in Bulgaria of the Company’s HIV/AIDS and...

October 7, 2014

NEW YORK--(BUSINESS WIRE)--Agilis Biotherapeutics, LLC, a synthetic biology-based company focused on developing DNA-based therapeutics for rare genetic diseases, announced today the addition of Professor Paola Leone, PhD, Director of the Cell and...

October 7, 2014

VALENCIA, Calif.--(BUSINESS WIRE)--Bioness today announced the launch of the Bioness Integrated Therapy System (BITS™).

October 7, 2014

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced that the U.S. Patent and Trademark Office has awarded the Company Patent No. 8,846,893, covering novel vectors for gene therapy treatments for cancers, virus infections and...

October 7, 2014

NESS ZIONA, Israel--(BUSINESS WIRE)--Kadimastem (TASE:KDST) announces today that only one day after approaching the FDA regarding the cellular treatment that it is developing for ALS, an encouraging response was received.

October 7, 2014

ST. LOUIS--(BUSINESS WIRE)--DiscoveryBioMed, Inc. (DBM, Inc.) learned in recent months that it was awarded a new Phase 1 SBIR grant from the National Institutes of Health (NIH) to perform high-throughput screening (HTS)-based drug discovery and...

October 7, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has successfully completed Cohort 6 of its...

October 7, 2014

WILMINGTON, Mass.--(BUSINESS WIRE)--Charles River Laboratories International, Inc. announced today that its integrated drug discovery collaboration with AstraZeneca has delivered an oral respiratory candidate drug for progression into preclinical...

October 7, 2014

CONCORD, Calif.--(BUSINESS WIRE)--FDA accepts Cerus’ clinical protocol to make INTERCEPT Platelets available under an Expanded Access IDE to regions in the United States with outbreaks of Chikungunya and dengue virus.

October 7, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business on October 6, 2014, the Company’s issued share capital, excluding...

October 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Eleven Biotherapeutics issued patent, which expires in 2031, containing both composition-of-matter and methods of use claims, strengthening the intellectual property portfolio for EBI-005.

October 7, 2014

GERMANTOWN, Wis.--(BUSINESS WIRE)--AAIPharma Services Corp. and Cambridge Major Laboratories, Inc. announce the appointments of Ted Dolan as Vice President, API Operations and Syed T. Husain as Vice President, API Business Unit.

October 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc., a biotechnology company focused on the development of therapeutic microbes, today announced the Bill & Melinda Gates Foundation has joined Atlas Venture and New Enterprise Associates (NEA) in...

October 7, 2014

PLEASANTON, Calif.--(BUSINESS WIRE)--Majority of CROs Exchange Regulated Clinical Trial Documents via Outdated, Hard-to-track Methods - New survey signals opportunity for CROs to create competitive advantage in rapidly growing market

October 7, 2014

PITTSBURGH--(BUSINESS WIRE)--CardiacAssist announced that the first PROTEK Duo case in the world was performed at Memorial Hermann Hospital in Houston, Texas on September 24, 2014.

October 7, 2014

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the biopharmaceutical division of Merck KGaA, Darmstadt, Germany, The Institute of Cancer Research (ICR), and the Wellcome Trust, London, today announced a co-development

October 7, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research is presenting at the 10th Annual Meeting of the Oligonucleotide Therapeutics Society being held on October 12-15, 2014 in San Diego.

October 7, 2014

BOUDRY, Switzerland--(BUSINESS WIRE)--Celgene to present Otezla data at European Academy of Dermatology and Venereology Congress

October 7, 2014

ABINGDON, England--(BUSINESS WIRE)--Atopix Therapeutics Ltd (“Atopix”), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, today announced the addition of SR One to its investor syndicate and the appointment...